WH [WSP] SC 13E3/A: Use these links to rapidly review the document

[Use these links to rapidly review the document , 2013 Shareholders of WSP Holdings Limited Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WSP Holdings Limited (the "Company") to be held on , 2013, at a.m. (Hong Kong time). The meeting will be held at] []

MPEL [Melco Crown Entertainment] 6-K: (Original Filing)

[(Incorporated in the Cayman Islands with limited liability) (SEHK stock code: 6883) UNAUDITED RESULTS FOR THE FIRST QUARTER OF 2013 Melco Crown Entertainment the Company ADSs Melco Crown Entertainment Limited (“ U.S. GAAP IFRS Net revenue for the first quarter of 2013 was US$1,144.9 million, representing an increase of approximately 11% from US$1,026.9 million for the comparable period in 2012.]

By | 2016-03-06T18:45:18+00:00 May 8th, 2013|Categories: Chinese Stocks, MPEL, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE May 8, 2013 China Biologic Reports Financial Results for the First Quarter of 2013 1Q13 Total Sales Increases 14.4% to $54.0 Million 1Q13 Operating Margin Increases to 48.1% from 1Q13 Non-GAAP Net Income 29.0% to $16.4 Million Increases BEIJING, China – May 8, 2013 – First Quarter 2013 Financial Highlights · Total sales · Gross profit · Income] []

MPEL [Melco Crown Entertainment] 6-K: (Incorporated in the Cayman Islands with limited liability)

[(Incorporated in the Cayman Islands with limited liability) (SEHK stock code: 6883) UNAUDITED RESULTS FOR THE FIRST QUARTER OF 2013 Melco Crown Entertainment the Company ADSs Melco Crown Entertainment Limited (“ U.S. GAAP IFRS Net revenue for the first quarter of 2013 was US$1,144.9 million, representing an increase of approximately 11% from US$1,026.9 million for the comparable period in 2012.]

By | 2016-03-06T18:46:46+00:00 May 8th, 2013|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: FOR RELEASE May 8, 2013 China Biologic Reports

[FOR RELEASE May 8, 2013 China Biologic Reports Financial Results for the First Quarter of 2013 1Q13 Total Sales Increases 14.4% to $54.0 Million 1Q13 Operating Margin Increases to 48.1% from 1Q13 Non-GAAP Net Income 29.0% to $16.4 Million Increases BEIJING, China – May 8, 2013 – First Quarter 2013 Financial Highlights · Total sales · Gross profit · Income] []

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. IN th David (Xiaoying) Gao Chief Executive Officer] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. IN th Ming Yang Chief Financial Officer (Principal Financial Officer)]

CBPO [China Biologic Products] 10-Q:

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. IN th David (Xiaoying) Gao Chief Executive Officer] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. IN th Ming Yang Chief Financial Officer (Principal Financial Officer)]

Skip to toolbar